Survival Benefit For Arimidex™ In Early Breast Cancer
12th Dec 2005, 03:30 GMT
Data presented at the San Antonio Breast Cancer Symposium (SABCS), Texas has found that 'Arimidex' (anastrozole) is the first aromatase inhibitor (AI) to provide an overall survival benefit, compared with tamoxifen, in the treatment of hormone-sensitive early breast cancer. According to this new analysis of data, by replacing tamoxifen with 'Arimidex', postmenopausal women being treated for early breast cancer may almost halve the likelihood of their disease returning and reduce their risk of dying by nearly a third... click link for more info.
Survival Benefit For Arimidex™ In Early Breast Cancer related news:
- Radiotherapy boosts survival rate for breast cancer patients: study — The Earth Times Online Newspaper
- Radiotherapy Offers Long-Term Survival Benefit In Breast Cancer — MedPage Today Hematology/Oncology
- Study Boosts Breast Cancer Survival — Sky News UK: Brings you closer to the news across Britain
- Radiotherapy aids breast cancer survival — MSNBC.com: Health
- 'I just got breast cancer.' — Breast Cancer Chronicles
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Gene variation affects tamoxifen's benefit for breast cancer — EurekAlert! - Cancer
- Radiation Benefit for Breast Cancer Shown — washingtonpost.com - Health
- SABCS: Taxotere-Cytoxan Combo Shows Survival Advantage in Breast Cancer Adjuvant Therapy — MedPage Today.com Latest Headlines
- Fabulous, thoughtful gifts for female related cancers — The Cancer Blog
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes